Internal Purdue documents showed executives knew OxyContin's 12-hour dosing often failed and the drug was highly addictive, contradicting their marketing claims.
“Purdue marketed OxyContin as having a low addiction potential due to its time-release formulation and 12-hour dosing schedule.”
From “crazy” to confirmed
The Claim Is Made
This is the moment they called it crazy.
No one's said anything yet. Be the first to drop your take.
